These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 33236048)

  • 1. Challenge Trials: What Are the Ethical Problems?
    Hausman DM
    J Med Philos; 2021 Jan; 46(1):137-145. PubMed ID: 33236048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Why continuing uncertainties are no reason to postpone challenge trials for coronavirus vaccines.
    Steel R; Buchak L; Eyal N
    J Med Ethics; 2020 Dec; 46(12):808-812. PubMed ID: 32661074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 vaccines: ethical framework concerning human challenge studies.
    Calina D; Hartung T; Docea AO; Spandidos DA; Egorov AM; Shtilman MI; Carvalho F; Tsatsakis A
    Daru; 2020 Dec; 28(2):807-812. PubMed ID: 32851596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Why Challenge Trials of SARS-CoV-2 Vaccines Could Be Ethical Despite Risk of Severe Adverse Events.
    Eyal N
    Ethics Hum Res; 2020 Jul; 42(4):24-34. PubMed ID: 32441894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity and safety of SARS-CoV-2 vaccines in clinical trials.
    Lim HX; Arip M; Yahaya AAA; Jazayeri SD; Poppema S; Poh CL
    Front Biosci (Landmark Ed); 2021 Nov; 26(11):1286-1304. PubMed ID: 34856768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2 vaccine testing and trials in the pediatric population: biologic, ethical, research, and implementation challenges.
    Cooper DM; Afghani B; Byington CL; Cunningham CK; Golub S; Lu KD; Radom-Aizik S; Ross LF; Singh J; Smoyer WE; Lucas CT; Tunney J; Zaldivar F; Ulloa ER
    Pediatr Res; 2021 Nov; 90(5):966-970. PubMed ID: 33627824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 Human Challenge Trials: Rethinking the Recruitment of Healthy Young Adults First.
    Matsui K; Inoue Y; Yamamoto K
    Ethics Hum Res; 2021 May; 43(3):37-41. PubMed ID: 33821569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enrolling Minors in COVID-19 Vaccine Trials.
    Mintz K; Jardas E; Shah S; Grady C; Danis M; Wendler D
    Pediatrics; 2021 Mar; 147(3):. PubMed ID: 33334920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Justifying the risks of COVID-19 challenge trials: The analogy with organ donation.
    Jayaram A; Sparks J; Callies D
    Bioethics; 2022 Jan; 36(1):100-106. PubMed ID: 34180072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Case for Human Challenge Trials in COVID-19.
    Drewett GP
    J Bioeth Inq; 2024 Mar; 21(1):151-165. PubMed ID: 37721594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prioritizing second-generation SARS-CoV-2 vaccines through low-dosage challenge studies.
    Steuwer B; Jamrozik E; Eyal N
    Int J Infect Dis; 2021 Apr; 105():307-311. PubMed ID: 33592338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 vaccine development: Time to consider SARS-CoV-2 challenge studies?
    Schaefer GO; Tam CC; Savulescu J; Voo TC
    Vaccine; 2020 Jul; 38(33):5085-5088. PubMed ID: 32540271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Covid-19 vaccine trials and ethics: Protection delayed is protection denied.
    John TJ; Dharmapalan D
    Indian J Med Ethics; 2021; VI(1):1-5. PubMed ID: 34080997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploration and Ethical Analysis of Open-label Pediatric Vaccine Trials in a Pandemic.
    Wolfe ID; Patel A; Kociolek LK; Fazal A; Jhaveri R; Lantos JD
    Clin Ther; 2021 Jun; 43(6):e163-e172. PubMed ID: 34039479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Ethics of Human Challenge Trials Using Emerging Severe Acute Respiratory Syndrome 2 Variants.
    Rohrig A; Eyal N
    J Infect Dis; 2022 Mar; 225(6):934-937. PubMed ID: 34624095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Africa's need for more COVID-19 clinical trials.
    Makoni M
    Lancet; 2021 May; 397(10289):2037. PubMed ID: 34062137
    [No Abstract]   [Full Text] [Related]  

  • 17. Testing SARS-CoV-2 vaccine efficacy through deliberate natural viral exposure.
    Eyal N; Lipsitch M
    Clin Microbiol Infect; 2021 Mar; 27(3):372-377. PubMed ID: 33421580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Ethics of Continuing Placebo in SARS-CoV-2 Vaccine Trials.
    Rid A; Lipsitch M; Miller FG
    JAMA; 2021 Jan; 325(3):219-220. PubMed ID: 33315080
    [No Abstract]   [Full Text] [Related]  

  • 19. Testing vaccines in the time of Covid: The changing landscape.
    Cash RA
    Indian J Med Ethics; 2021; VI(2):1-4. PubMed ID: 33908357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Key criteria for the ethical acceptability of COVID-19 human challenge studies: Report of a WHO Working Group.
    Jamrozik E; Littler K; Bull S; Emerson C; Kang G; Kapulu M; Rey E; Saenz C; Shah S; Smith PG; Upshur R; Weijer C; Selgelid MJ;
    Vaccine; 2021 Jan; 39(4):633-640. PubMed ID: 33341309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.